[April 12, 2012]

Research and Markets: Biotech Company Needs Assessment for Outsourcing Practices for Phase I, Phase II/III, and Phase IIIb/IV Studies

Dublin - Research and Markets (http://www.researchandmarkets.com/research/2318249b/biotech_company_ne) has announced the addition of the "Biotech Company Needs Assessment" report to their offering.

Biotechnology Company Needs Assessment provides a detailed analysis of biotechnology companies' drug development outsourcing practices for Phase I, Phase II/III, and Phase IIIb/IV studies. In particular, the report examines how outsourcing decisions are made for each phase of development, who the preferred service providers are, and how much outsourcing biotech companies plan to do by phase in the next year. The report also showcases the large CROs' satisfaction and loyalty profiles for delivering to biotechnology companies. CROs can rely on this report to sharpen their sales and marketing strategies to this critical segment of sponsors and more intelligently set sales and marketing goals. Biotechnology companies can rely on this report to make more informed CR selections and increase their chances of partnership success.

THis Report Contains the Following Four Sections:

1. Industry Perceptions: This section outlines which service providers are seen as industry leaders, which providers are preferred by sponsors, and which are being used by respondents. These data are split by Phase I, Phase II/III and Phase IIIb/IV services.

2. Market Dynamics: This section details sponsors' reports of outsourcing levels - by phase - for the past 12 months and for the next 12 months.

3. Biotech Company Needs: This section identifies several nuances about selling and delivering to biotechnology companies that set them apart from large pharma.

4. Service Provider Selection: This section calls out the important criteria by which sponsor companies select their providers and identifies which CRO attributes are increasing in importance.

An appendix of Charts and Graphs is also included within this report with responses to all questions asked in this study.

What Readers Will Know:

Service Providers will learn...

- Which service provider attributes biotech companies think are most important by phase of development (I, II/III, IV) and which are gaining importance..

- How best to differentiate your company for this market segment..

- Where these companies will be spending more and less in the future

Biopharmaceutical Companies will learn...

- Who the leading service providers are to the biotech market segment? (select providers with more confidence)

- Which attributes the large CROs excel at and where they don't measure up? (modify contracts to ensure performance expectations are met)

- How service providers may differentiate themselves? (prepare your procurement function to evaluate these options)

Companies Mentioned:

- Covance

- ICON

- PAREXEL

- PPD

- Quintiles

For more information visit http://www.researchandmarkets.com/research/2318249b/biotech_company_ne

[ Back To TMCnet.com's Homepage ]